(Q73828898)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10828860%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10828860%20AND%20SRC:MED&resulttype=core&format=json

stem cell transplantation

7 November 2019

main subject

1 reference

Nagler A

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10828860%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Slavin S

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10828860%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Varadi G

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10828860%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Naparstek E

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10828860%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Samuel S

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10828860%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Or R

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10828860%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10828860%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10828860%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10828860%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10828860%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

1021-1028

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10828860%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702392

7 November 2019

exact match

0 references

cites work

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

High-dose chemotherapy and autologous bone marrow transplantation for malignant lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Randomized trial showing equivalent efficacy of filgrastim 5 micrograms/kg/d and 10 micrograms/kg/d following high-dose chemotherapy and autologous bone marrow transplantation in high-risk lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

New developments in bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Invasive fungal infections in lymphoma patients receiving immunotherapy following autologous bone marrow transplantation (ABMT)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Immunotherapy in conjunction with autologous and allogeneic blood or marrow transplantation in lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

High-dose chemotherapy, fractionated total-body irradiation, and allogeneic marrow transplantation for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Immunosuppression with purine analogues--the flip side of the gold coin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Variable number of tandem repeat (VNTR) markers for human gene mapping

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Mismatched transplants for refractory lymphoma?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Graft-versus-leukemia effect in MHC-compatible and -incompatible allogeneic bone marrow transplantation of radiation-induced, leukemia-bearing mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021

Allogeneic bone marrow transplantation with T-cell-depleted marrow grafts for patients with poor-risk relapsed low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702392

7 January 2021